home > ict > summer 2019 > moving in a new direction
International Clinical Trials

Moving in a New Direction

ICT: ‘Partnerships in Clinical Trials Europe’ has a 18 year legacy. Why the change in name to ‘Clinical Trials Europe’?

Louisa Maitland: Historically, the focus of Partnerships in Clinical Trials Europe was the ‘partnership’ between a CRO and a sponsor company; however, the industry has evolved over the last 18 years and so has the view of partnerships. Increasingly complex partnerships between consortiums, patients, patient advocacy groups, sponsors, academic institutions, consultants, CROs, vendors, suppliers, and more that are driving major strategic, operational, and technology developments are all addressed within this year’s agenda. With this in mind, it was important that the event title was broad enough to reflect the vast content covered and the industry’s progress: hence, Clinical Trials Europe (CTE).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

About the author

Louisa Maitland at KNect365 Life Sciences, UK, has been working as the Conference Director for Partnerships in Clinical Trials Europe for the last five years and has worked for a total of 16 years at Informa producing a variety of conferences, but mainly specialising in biologic manufacturing. After gaining a BSc at Reading University, UK, in Environmental Science, Louisa then studied Forensic Science at Kings College London, UK, where she gained an MSc. She started her career working at the Poisons Unit as a Forensic Toxicologist, and then worked for five years at GlaxoSmithKline as a Biochemist analysing clinical trials.

Print this page
Send to a friend
Privacy statement
News and Press Releases

Avacta and Cytiva collaborating on COVID-19 rapid test

Cambridge and Wetherby, UK, 08 April 2020: Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences. The companies will develop and manufacture an Affimer-based point-of-care rapid test intended for screening of large populations to diagnose the COVID-19 coronavirus infection.
More info >>

White Papers

Mauritius Island – An Emerging Centre for R&D in Biotechnology and the Life Sciences

CIDP (Centre International de Développement Pharmaceutique)

Mauritius, the tropical island situated in the Indian Ocean and known worldwide for its beautiful beaches, is also internationally recognised for its rule of law, and political and social stability. Over the past few years, the economy has been successfully transitioned from a monocrop to a diversified innovation-driven and knowledge-based economy, resting on agribusiness, export-oriented manufacturing, tourism, financial services, property development and real estate, ICT-BPO, the seafood industry, a free port, logistics and a nascent ocean economy. Emerging sectors such as healthcare and life sciences are presenting some niche areas for the taking, and the enabling environment is being put in place to make it happen - especially in the light of sustained growth within pharmaceutical, medical device, and clinical research. Important international players are already in operation locally as the country has established the appropriate legal and regulatory frameworks based on international norms, for the development of a strong biomedical research sector.
More info >>

Industry Events

Outsourcing in Clinical Trials Europe

26-27 October 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement